Blue Abstract Wave Banner

Key Information

Chief Investigator: Dr Jonathan Krell

ICTU collaboration: Operations; Statistics;Database

Email: dice-trial@imperial.ac.uk

Study website: Clinical trials

Trial registration:  EudraCT Number: 2016-000065-23 

Clinical Trial. Gov: NCT03648489

Status: Follow-up

DICE: Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high grade serous type, and carcinosarcoma)

An international multi-centre randomised phase II study to assess the efficacy of TAK228 in combination with intravenous weekly paclitaxel compared with weekly paclitaxel alone in women with advanced/recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high grade serous type, and carcinosarcoma)

Therapeutic areas contacts

For contact details please visit Therapeutic areas contacts